Teriparatide is the only anabolic (i.e., bone growing) agent indicated for use in postmenopausal women with osteoporosis at a high risk for fracture or with a history of osteoporotic fracture, patients with multiple risk factors for fracture, and for patients who have failed or are intolerant to other available osteoporosis therapy. It has been FDA-approved since 2002. It is effective in growing bone (e.g., 8% increase in bone density in the spine after one year) and reducing the risk of fragility fractures. Osteoporosis medications are generally safe, but some side effects of teriparatide include headache, nausea, dizziness, and limb pain.

1.Helping restore the suppleness and firmness of skin. 
2.Increase HA and collage,anti-aging. 
3. Producing chemotaxis for reconstructing and repair, reconstruction of dermis,significantly stimulated human skin fibroblast proliferation. 
4.Based on glycerin water solution,absorbed easily by skin.